Single nucleotide polymorphisms in the vitamin D pathway associating with circulating concentrations of vitamin D metabolites and non-skeletal health outcomes: Review of genetic association studies

Journal of Steroid Biochemistry and Molecular Biology

Volumn 164, Issue , 2016, Pages 18-29

  Jolliffe, David A ^a   Walton, Robert T ^a   Griffiths, Christopher J ^a   Martineau, Adrian R ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Candidate gene association studies; Genome wide association studies; Non skeletal diseases; Single nucleotide polymorphism; Vitamin D; Vitamin D status

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CHOLESTANETRIOL 26 MONOOXYGENASE; COLECALCIFEROL 24 HYDROXYLASE; CUB PROTEIN; CYP27B1 PROTEIN; CYP2R1 PROTEIN; CYTOCHROME P450 3A4; DHCR7 PROTEIN; LRP2 PROTEIN; PHTHALIC ACID DIBUTYL ESTER; PROTEIN; RXRA PROTEIN; UNCLASSIFIED DRUG; VDR PROTEIN; VITAMIN D; 7-DEHYDROCHOLESTEROL REDUCTASE; CALCIDIOL 1 MONOOXYGENASE; CALCITRIOL RECEPTOR; CYP27B1 PROTEIN, HUMAN; CYP2R1 PROTEIN, HUMAN; CYTOCHROME P450 FAMILY 2; DBP PROTEIN, HUMAN; DNA BINDING PROTEIN; OXIDOREDUCTASE; PROTEIN BINDING; TRANSCRIPTION FACTOR; VDR PROTEIN, HUMAN;

AUTOIMMUNE DISEASE; DISEASE ASSOCIATION; GENETIC ASSOCIATION; GENETIC ASSOCIATION STUDY; GENETIC VARIATION; GENOTYPE; HUMAN; MEDLINE; OUTCOME ASSESSMENT; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; VITAMIN BLOOD LEVEL; AUTOIMMUNITY; BLOOD; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; META ANALYSIS (TOPIC); MUTATION; PHENOTYPE; RISK; TREATMENT OUTCOME;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; AUTOIMMUNITY; CHOLESTANETRIOL 26-MONOOXYGENASE; CYTOCHROME P450 FAMILY 2; DNA-BINDING PROTEINS; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; META-ANALYSIS AS TOPIC; MUTATION; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN BINDING; RECEPTORS, CALCITRIOL; RISK; TRANSCRIPTION FACTORS; TREATMENT OUTCOME; VITAMIN D;

EID: 84960858907     PISSN: 09600760     EISSN: 18791220     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2015.12.007     Document Type: Review

References (130)

1. [1] Morrison, N.A., Yeoman, R., Kelly, P.J., Eisman, J.A., Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc. Natl. Acad. Sci. U. S. A. 89:15 (1992), 6665–6669.
2. [2] Morrison, N.A., Qi, J.C., Tokita, A., Kelly, P.J., Crofts, L., Nguyen, T.V., et al. Prediction of bone density from vitamin D receptor alleles. Nature 367:6460 (1994), 284–287.
3. [3] Tizaoui, K., Berraies, A., Hamdi, B., Kaabachi, W., Hamzaoui, K., Hamzaoui, A., Association of vitamin D receptor gene polymorphisms with asthma risk: systematic review and updated meta-analysis of case–control studies. Lung 192:6 (2014), 955–965.
4. [4] Ahn, J., Albanes, D., Berndt, S.I., Peters, U., Chatterjee, N., Freedman, N.D., et al. Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk. Carcinogenesis 30:5 (2009), 769–776.
5. [5] Gao, L., Tao, Y., Zhang, L., Jin, Q., Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int. J. Tuberculosis Lung Dis. 14:1 (2010), 15–23.
6. [6] Tizaoui, K., Kaabachi, W., Hamzaoui, A., Hamzaoui, K., Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case–control studies. Cell. Mol. Immunol. 12:2 (2015), 243–252.
7. [7] Mohammadi, Z., Fayyazbakhsh, F., Ebrahimi, M., Amoli, M.M., Khashayar, P., Dini, M., et al. Association between vitamin D receptor gene polymorphisms (Fok1 and Bsm1) and osteoporosis: a systematic review. J. Diabetes Metab. Disorders, 13(1), 2014, 98.
8. [8] Bhan, I., Vitamin D binding protein and bone health. Int. J. Endocrinol., 2014, 2014, 561214.
9. [9] Wang, T.J., Zhang, F., Richards, J.B., Kestenbaum, B., van Meurs, J.B., Berry, D., et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376:9736 (2010), 180–188.
10. [10] Ahn, J., Yu, K., Stolzenberg-Solomon, R., Simon, K.C., McCullough, M.L., Gallicchio, L., et al. Genome-wide association study of circulating vitamin D levels. Hum. Mol. Genet. 19:13 (2010), 2739–2745.
11. [11] Martineau, A.R., Timms, P.M., Bothamley, G.H., Hanifa, Y., Islam, K., Claxton, A.P., et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 377:9761 (2011), 242–250.
12. 3 supplementation in adults with asthma (ViDiAs). Thorax 70:5 (2015), 451–457.
13. [13] Engelman, C.D., Fingerlin, T.E., Langefeld, C.D., Hicks, P.J., Rich, S.S., Wagenknecht, L.E., et al. Genetic and environmental determinants of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels in Hispanic and African Americans. J. Clin. Endocrinol. Metab. 93:9 (2008), 3381–3388.
14. 3 levels are associated with adverse outcome in newly diagnosed, intensively treated adult acute myeloid leukemia. Cancer 120:4 (2014), 521–529.
15. [15] Lauridsen, A.L., Vestergaard, P., Hermann, A.P., Brot, C., Heickendorff, L., Mosekilde, L., et al. Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcified Tissue Int. 77:1 (2005), 15–22.
16. [16] Kurylowicz, A., Ramos-Lopez, E., Bednarczuk, T., Badenhoop, K., Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves’ disease and the vitamin D status in a polish population study. Exp. Clin. Endocrinol. Diabetes 114:6 (2006), 329–335.
17. 3 serum levels in asthma families. J. Steroid Biochem. Mol. Biol. 103 (2007), 799–802.
18. [18] Abbas, S., Linseisen, J., Slanger, T., Kropp, S., Mutschelknauss, E.J., Flesch-Janys, D., et al. The Gc2 allele of the vitamin D binding protein is associated with a decreased postmenopausal breast cancer risk, independent of the vitamin D status. Cancer Epidemiol. Biomarkers Prev. 17:6 (2008), 1339–1343.
19. [19] Fu, L., Yun, F., Oczak, M., Wong, B.Y., Vieth, R., Cole, D.E., Common genetic variants of the vitamin D binding protein (DBP) predict differences in response of serum 25-hydroxyvitamin D [25(OH)D] to vitamin D supplementation. Clin. Biochem. 42:10–11 (2009), 1174–1177.
20. [20] Sinotte, M., Diorio, C., Berube, S., Pollak, M., Brisson, J., Genetic polymorphisms of the vitamin D binding protein and plasma concentrations of 25-hydroxyvitamin D in premenopausal women. Am. J. Clin. Nutr. 89:2 (2009), 634–640.
21. [21] Fang, Y., van Meurs, J.B., Arp, P., van Leeuwen, J.P., Hofman, A., Pols, H.A., et al. Vitamin D binding protein genotype and osteoporosis. Calcified Tissue Int. 85:2 (2009), 85–93.
22. [22] Janssens, W., Bouillon, R., Claes, B., Carremans, C., Lehouck, A., Buysschaert, I., et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 65:3 (2010), 215–220.
23. [23] Robien, K., Butler, L.M., Wang, R., Beckman, K.B., Walek, D., Koh, W.P., et al. Genetic and environmental predictors of serum 25-hydroxyvitamin D concentrations among middle-aged and elderly Chinese in Singapore. Br. J. Nutr. 109:3 (2013), 493–502.
24. [24] Hibler, E.A., Hu, C., Jurutka, P.W., Martinez, M.E., Jacobs, E.T., Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia. Cancer Epidemiol. Biomarkers Prev. 21:2 (2012), 368–375.
25. [25] Lu, L., Sheng, H., Li, H., Gan, W., Liu, C., Zhu, J., et al. Associations between common variants in GC and DHCR7/NADSYN1 and vitamin D concentration in Chinese Hans. Hum. Genet. 131:3 (2012), 505–512.
26. [26] Zhang, Z., He, J.-W., Fu, W.-Z., Zhang, C.-Q., Zhang, Z.-L., An analysis of the association between the vitamin D pathway and serum 25-hydroxyvitamin D levels in a healthy Chinese population. J. Bone Miner. Res. 28:8 (2013), 1784–1792.
27. [27] Perna, L., Felix, J.F., Breitling, L.P., Haug, U., Raum, E., Burwinkel, B., et al. Genetic variations in the vitamin D binding protein and season-specific levels of vitamin D among older adults. Epidemiology 24:1 (2013), 104–109.
28. [28] Suaini, N.H., Koplin, J.J., Ellis, J.A., Peters, R.L., Ponsonby, A.L., Dharmage, S.C., et al. Environmental and genetic determinants of vitamin D insufficiency in 12-month-old infants. J. Steroid Biochem. Mol. Biol. 144:Pt B (2014), 445–454.
29. [29] Elkum, N., Alkayal, F., Noronha, F., Ali, M.M., Melhem, M., Al-Arouj, M., et al. Vitamin D insufficiency in Arabs and South Asians positively associates with polymorphisms in GC and CYP2R1 genes. PLoS One, 9(11), 2014, e113102.
30. [30] Anderson, D., Holt, B.J., Pennell, C.E., Holt, P.G., Hart, P.H., Blackwell, J.M., Genome-wide association study of vitamin D levels in children: replication in the Western Australian pregnancy cohort (Raine) study. Genes Immun. 15:8 (2014), 578–583.
31. [31] Nissen, J., Rasmussen, L.B., Ravn-Haren, G., Andersen, E.W., Hansen, B., Andersen, R., et al. Common variants in CYP2R1 and GC genes predict vitamin D concentrations in healthy Danish children and adults. PLoS One, 9(2), 2014, e89907.
32. [32] Wood, A.M., Bassford, C., Webster, D., Newby, P., Rajesh, P., Stockley, R.A., et al. Vitamin D-binding protein contributes to COPD by activation of alveolar macrophages. Thorax 66:3 (2011), 205–210.
33. [33] Signorello, L.B., Shi, J., Cai, Q., Zheng, W., Williams, S.M., Long, J., et al. Common variation in vitamin D pathway genes predicts circulating 25-hydroxyvitamin D levels among African Americans. PLoS One, 6(12), 2011, e28623.
34. [34] Xu, W., Sun, J., Wang, W., Wang, X., Jiang, Y., Huang, W., et al. Association of genetic variants of vit D binding protein (DBP/GC) and of the enzyme catalyzing its 25-hydroxylation (DCYP2R1) and serum vit D in postmenopausal women. Hormones 13:3 (2014), 345–352.
35. 3 supplementation for increasing serum 25-hydroxyvitamin D levels in a randomized controlled trial. J. Clin. Endocrinol. Metab. 99:10 (2014), E2133–E2137.
36. [36] Cheung, C.-L., Lau, K.-S., Sham, P.-C., Tan, K.C.B., Kung, A.W.C., Genetic variant in vitamin D binding protein is associated with serum 25-hydroxyvitamin D and vitamin D insufficiency in southern Chinese. J. Hum. Genet. 58:11 (2013), 749–751.
37. [37] Ramos-Lopez, E., Bruck, P., Jansen, T., Herwig, J., Badenhoop, K., CYP2R1 (vitamin D 25-hydroxylase) gene is associated with susceptibility to type 1 diabetes and vitamin D levels in Germans. Diabetes Metab. Res. Rev. 23:8 (2007), 631–636.
38. [38] Hassanein, S.I., Abu El Maaty, M.A., Sleem, H.M., Gad, M.Z., Triangular relationship between single nucleotide polymorphisms in the CYP2R1 gene (rs10741657 and rs12794714), 25-hydroxyvitamin D levels, and coronary artery disease incidence. Biomarkers 19:6 (2014), 488–492.
39. [39] Batai, K., Murphy, A.B., Shah, E., Ruden, M., Newsome, J., Agate, S., et al. Common vitamin D pathway gene variants reveal contrasting effects on serum vitamin D levels in African Americans and European Americans. Hum. Genet. 133:11 (2014), 1395–1405.
40. [40] Ye, Z., Sharp, S.J., Burgess, S., Scott, R.A., Imamura, F., InterAct Consortium, et al. Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 3:1 (2015), 35–42.
41. [41] Azad, A.K., Bairati, I., Qiu, X., Huang, H., Cheng, D., Liu, G., et al. Genetic sequence variants in vitamin D metabolism pathway genes, serum vitamin D level and outcome in head and neck cancer patients. Int. J. Cancer 132:11 (2013), 2520–2527.
42. [42] Cooper, J.D., Smyth, D.J., Walker, N.M., Stevens, H., Burren, O.S., Wallace, C., et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes 60:5 (2011), 1624–1631.
43. [43] Pillai, D.K., Iqbal, S.F., Benton, A.S., Lerner, J., Wiles, A., Foerster, M., et al. Associations between genetic variants in vitamin D metabolism and asthma characteristics in young African Americans: a pilot study. J. Invest. Med. 59:6 (2011), 938–946.
44. [44] Hypponen, E., Berry, D.J., Wjst, M., Power, C., Serum 25-hydroxyvitamin D and IgE—a significant but nonlinear relationship. Allergy 64:4 (2009), 613–620.
45. [45] Lange, C.M., Bojunga, J., Ramos-Lopez, E., von Wagner, M., Hassler, A., Vermehren, J., et al. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy. J. Hepatol. 54:5 (2011), 887–893.
46. [46] Ramagopalan, S.V., Dyment, D.A., Cader, M.Z., Morrison, K.M., Disanto, G., Morahan, J.M., et al. Rare variants in the CYP27B1 gene are associated with multiple sclerosis. Ann. Neurol. 70:6 (2011), 881–886.
47. [47] Orton, S.M., Morris, A.P., Herrera, B.M., Ramagopalan, S.V., Lincoln, M.R., Chao, M.J., et al. Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am. J. Clin. Nutr. 88:2 (2008), 441–447.
48. [48] Zhang, Y., Wang, X., Liu, Y., Qu, H., Qu, S., Wang, W., et al. The GC, CYP2R1 and DHCR7 genes are associated with vitamin D levels in northeastern Han Chinese children. Swiss Med. Weekly, 142, 2012, w13636.
49. [49] Strawbridge, R.J., Deleskog, A., McLeod, O., Folkersen, L., Kavousi, M., Gertow, K., et al. A serum 25-hydroxyvitamin D concentration-associated genetic variant in DHCR7 interacts with type 2 diabetes status to influence subclinical atherosclerosis (measured by carotid intima-media thickness). Diabetologia 57:6 (2014), 1159–1172.
50. [50] Voipio, A.J., Pahkala, K.A., Viikari, J.S., Mikkila, V., Magnussen, C.G., Hutri-Kahonen, N., et al. Determinants of serum 25(OH)D concentration in young and middle-aged adults. The cardiovascular risk in young Finns study. Ann. Med. 47:3 (2015), 253–262.
51. [51] Davies, J.R., Chang, Y.M., Snowden, H., Chan, M., Leake, S., Karpavicius, B., et al. The determinants of serum vitamin D levels in participants in a melanoma case–control study living in a temperate climate. Cancer Causes Control 22:10 (2011), 1471–1482.
52. [52] Hibler, E.A., Jurutka, P.W., Egan, J.B., Hu, C., LeRoy, E.C., Martinez, M.E., et al. Association between polymorphic variation in VDR and RXRA and circulating levels of vitamin D metabolites. J. Steroid Biochem. Mol. Biol. 121:1–2 (2010), 438–441.
53. [53] Kresfelder, T.L., Janssen, R., Bont, L., Pretorius, M., Venter, M., Confirmation of an association between single nucleotide polymorphisms in the VDR gene with respiratory syncytial virus related disease in South African children. J. Med. Virol. 83:10 (2011), 1834–1840.
54. [54] Wilkinson, R.J., Llewelyn, M., Toossi, Z., Patel, P., Pasvol, G., Lalvani, A., et al. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in westLondon: a case–control study. Lancet 355:9204 (2000), 618–621.
55. [55] Zhang, H.-Q., Deng, A., Guo, C.-F., Wang, Y.-X., Chen, L.-Q., Wang, Y.-F., et al. Association between FokI polymorphism in vitamin D receptor gene and susceptibility to spinal tuberculosis in Chinese Han population. Arch. Med. Res. 41:1 (2010), 46–49.
56. [56] Sharma, P.R., Singh, S., Jena, M., Mishra, G., Prakash, R., Das, P.K., et al. Coding and non-coding polymorphisms in VDR gene and susceptibility to pulmonary tuberculosis in tribes, castes and Muslims of Central India. Infect. Genet. Evol. 11:6 (2011), 1456–1461.
57. [57] Lee, Y.H., Choi, S.J., Ji, J.D., Song, G.G., Vitamin D receptor ApaI, TaqI, BsmI, and FokI polymorphisms and psoriasis susceptibility: a meta-analysis. Mol. Biol. Rep. 39:6 (2012), 6471–6478.
58. [58] Li, J.H., Li, H.Q., Li, Z., Liu, Y., Gao, J.R., Zeng, X.J., et al. Association of Taq I T/C and Fok I C/T polymorphisms of vitamin D receptor gene with outcome of hepatitis B virus infection. Zhonghua yi xue za zhi 86:28 (2006), 1952–1956.
59. [59] Roth, D.E., Jones, A.B., Prosser, C., Robinson, J.L., Vohra, S., Vitamin D receptor polymorphisms and the risk of acute lower respiratory tract infection in early childhood. J. Infect. Dis. 197:5 (2008), 676–680.
60. [60] Aslan, S., Akil, I., Aslan, G., Onay, H., Ozyurt, B.C., Ozkinay, F., Vitamin D receptor gene polymorphism in children with urinary tract infection. Pediatr. Nephrol. 27:3 (2012), 417–421.
61. [61] Nabih, E.S., Kamel, T.B., Association between vitamin D receptor gene FokI polymorphism and atopic childhood bronchial asthma. Egypt. J. Chest Dis. Tuberculosis 63:3 (2014), 547–552.
62. [62] Swapna, N., Vamsi, U.M., Usha, G., Padma, T., Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension. Indian J. Hum. Genet. 17:3 (2011), 201–206.
63. [63] Luo, X.Y., Wu, L.J., Yang, M.H., Liu, N.T., Liao, T., Tang, Z., et al. Relationship of vitamin D receptor gene Fok I polymorphism with systemic lupus erythematosus. Xi bao yu fen zi mian yi xue za zhi (Chinese journal of cellular and molecular immunology) 27:8 (2011), 901–905.
64. [64] Arjumand, W., Ahmad, S.T., Seth, A., Saini, A.K., Sultana, S., Vitamin D receptor FokI and BsmI gene polymorphism and its association with grade and stage of renal cell carcinoma in North Indian population. Tumour Biol. 33:1 (2012), 23–31.
65. [65] Lee, Y.H., Bae, S.-C., Choi, S.J., Ji, J.D., Song, G.G., Associations between vitamin D receptor polymorphisms and susceptibility to rheumatoid arthritis and systemic lupus erythematosus: a meta-analysis. Mol. Biol. Rep. 38:6 (2011), 3643–3651.
66. [66] Mun, M.J., Kim, T.H., Hwang, J.Y., Jang, W.C., Vitamin D receptor gene polymorphisms and the risk for female reproductive cancers: a meta-analysis. Maturitas 81:2 (2015), 256–265.
67. [67] Penna-Martinez, M., Ramos-Lopez, E., Stern, J., Hinsch, N., Hansmann, M.L., Selkinski, I., et al. Vitamin D receptor polymorphisms in differentiated thyroid carcinoma. Thyroid 19:6 (2009), 623–628.
68. [68] Panierakis, C., Goulielmos, G., Mamoulakis, D., Petraki, E., Papavasiliou, E., Galanakis, E., Vitamin D receptor gene polymorphisms and susceptibility to type 1 diabetes in Crete, Greece. Clin. Immunol. 133:2 (2009), 276–281.
69. [69] Gao, Z., Fu, H.J., Xue, J.J., Wu, Z.X., Zhao, L.B., Genetic polymorphisms in VDR, ESR1 and ESR2 genes may contribute to susceptibility to Parkinson's disease: a meta-analysis. Mol. Biol. Rep. 41:7 (2014), 4463–4474.
70. [70] Messaritakis, I., Samonis, G., Dimopoulou, D., Maraki, S., Papadakis, J.A., Daraki, V., et al. Staphylococcus aureus nasal carriage might be associated with vitamin D receptor polymorphisms in type 2 diabetes. Clin. Microbiol. Infect. 20:9 (2014), 920–925.
71. [71] Zhong, X., Du, Y., Lei, Y., Liu, N., Guo, Y., Pan, T., Effects of vitamin D receptor gene polymorphism and clinical characteristics on risk of diabetic retinopathy in Han Chinese type 2 diabetes patients. Gene 566:2 (2015), 212–216.
72. [72] Moodley, A., Qin, M., Singh, K.K., Spector, S.A., Vitamin D-related host genetic variants alter HIV disease progression in children. Pediatr. Infect. Dis. J. 32:11 (2013), 1230–1236.
73. [73] Torres, C., Sanchez de la Torre, M., Garcia-Moruja, C., Carrero, A.J., Trujillo Mdel, M., Fibla, J., et al. Immunophenotype of vitamin D receptor polymorphism associated to risk of HIV-1 infection and rate of disease progression. Curr. HIV Res. 8:6 (2010), 487–492.
74. [74] Feng, M., Li, H., Chen, S.-F., Li, W.-F., Zhang, F.-B., Polymorphisms in the vitamin D receptor gene and risk of autoimmune thyroid diseases: a meta-analysis. Endocrine 43:2 (2013), 318–326.
75. [75] Testa, A., Mallamaci, F., Benedetto, F.A., Pisano, A., Tripepi, G., Malatino, L., et al. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients. J. Bone Miner. Res. 25:2 (2010), 313–319.
76. [76] Jia, F., Sun, R.F., Li, Q.H., Wang, D.X., Zhao, F., Li, J.M., et al. Vitamin D receptor BsmI polymorphism and osteoporosis risk: a meta-analysis from 26 studies. Genet. Test. Mol. Biomarkers 17:1 (2013), 30–34.
77. [77] Jenab, M., McKay, J., Bueno-de-Mesquita, H.B., van Duijnhoven, F.J.B., Ferrari, P., Slimani, N., et al. Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Cancer Epidemiol. Biomarkers Prev. 18:9 (2009), 2485–2491.
78. [78] Orlow, I., Roy, P., Reiner, A.S., Yoo, S., Patel, H., Paine, S., et al. Vitamin D receptor polymorphisms in patients with cutaneous melanoma. Int. J. Cancer 130:2 (2012), 405–418.
79. [79] Deng, H., Liu, F., Pan, Y., Jin, X., Wang, H., Cao, J., BsmI, TaqI, ApaI, and FokI polymorphisms in the vitamin D receptor gene and periodontitis: a meta-analysis of 15 studies including 1338 cases and 1302 controls. J. Clin. Periodontol. 38:3 (2011), 199–207.
80. [80] Li, L., Wu, Y., Li, L., Cai, Y.F., Geng, L., Gao, X.H., et al. Association of ApaI and BsmI polymorphisms with vitiligo risk: a meta-analysis. Clin. Exp. Dermatol., 2015.
81. [81] Ou, C., Zhao, H.L., Zhu, B., Huang, L.S., Li, P.Z., Lao, M., Association of vitamin D receptor gene polymorphism with the risk of renal cell carcinoma: a meta-analysis. J. Recept. Signal Transduct. Res. 34:6 (2014), 463–468.
82. [82] Liu, S.G., Li, Y.Y., Sun, R.X., Wang, J.L., Li, X.D., Han, L., et al. Polymorphisms in the vitamin D receptor and risk of gout in Chinese Han male population. Rheumatol. Int. 35:6 (2015), 963–971.
83. [83] Saito, M., Eiraku, N., Usuku, K., Nobuhara, Y., Matsumoto, W., Kodama, D., et al. ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals. J. Neurol. Sci 232:1-2 (2005), 29–35.
84. [84] Mahmoudi, T., Mohebbi, S.R., Pourhoseingholi, M.A., Fatemi, S.R., Zali, M.R., Vitamin D receptor gene ApaI polymorphism is associated with susceptibility to colorectal cancer. Dig. Dis. Sci. 55:7 (2010), 2008–2013.
85. 3 in patients with Graves disease in an Egyptian population: a pilot study. Endocr. Pract. 18:2 (2012), 132–139.
86. [86] Saadi, A., Gao, G., Li, H., Wei, C., Gong, Y., Liu, Q., Association study between vitamin D receptor gene polymorphisms and asthma in the Chinese Han population: a case–control study. BMC Med. Genet., 10, 2009, 71.
87. [87] Onen, I.H., Ekmekci, A., Eroglu, M., Konac, E., Yesil, S., Biri, H., Association of genetic polymorphisms in vitamin D receptor gene and susceptibility to sporadic prostate cancer. Exp. Biol. Med. 233:12 (2008), 1608–1614.
88. [88] Jingwi, E.Y., Abbas, M., Ricks-Santi, L., Winchester, D., Beyene, D., Day, A., et al. Vitamin D receptor genetic polymorphisms are associated with PSA level, Gleason score and prostate cancer risk in African-American men. Anticancer Res. 35:3 (2015), 1549–1558.
89. [89] Baur, K., Mertens, J.C., Schmitt, J., Iwata, R., Stieger, B., Eloranta, J.J., et al. Combined effect of 25-OH vitamin D plasma levels and genetic vitamin D receptor (NR 1I1) variants on fibrosis progression rate in HCV patients. Liver Int. 32:4 (2012), 635–643.
90. [90] Heine, G., Hoefer, N., Franke, A., Nothling, U., Schumann, R.R., Hamann, L., et al. Association of vitamin D receptor gene polymorphisms with severe atopic dermatitis in adults. Br. J. Dermatol. 168:4 (2013), 855–858.
91. [91] Dalessandri, K.M., Miike, R., Wiencke, J.K., Farren, G., Pugh, T.W., Manjeshwar, S., et al. Vitamin D receptor polymorphisms and breast cancer risk in a high-incidence population: a pilot study. J. Am. Coll. Surg. 215:5 (2012), 652–657.
92. [92] Hung, C.H., Chiu, Y.C., Hu, T.H., Chen, C.H., Lu, S.N., Huang, C.M., et al. Significance of vitamin d receptor gene polymorphisms for risk of hepatocellular carcinoma in chronic hepatitis C. Transl. oncol. 7:4 (2014), 503–507.
93. [93] Neela, V.S., Suryadevara, N.C., Shinde, V.G., Pydi, S.S., Jain, S., Jonnalagada, S., et al. Association of Taq I, Fok I and Apa I polymorphisms in vitamin D receptor (VDR) gene with leprosy. Hum. Immunol., 2015.
94. [94] Alagarasu, K., Honap, T., Mulay, A.P., Bachal, R.V., Shah, P.S., Cecilia, D., Association of vitamin D receptor gene polymorphisms with clinical outcomes of dengue virus infection. Hum. Immunol. 73:11 (2012), 1194–1199.
95. [95] Bektas-Kayhan, K., Unur, M., Yaylim-Eraltan, I., Ergen, H.A., Toptas, B., Hafiz, G., et al. Association of vitamin D receptor Taq I polymorphism and susceptibility to oral squamous cell carcinoma. In Vivo 24:5 (2010), 755–759.
96. [96] Carvalho, C., et al. Association between vitamin D receptor (VDR) gene polymorphisms and systemic lupus erythematosus in Portuguese patients. Lupus, 2015 [Epub ahead of print].
97. [97] Li, Y.J., Tang, Y.W., Shi, Y.Q., Han, S., Wang, J.B., Zhou, X.M., et al. Polymorphisms in the vitamin D receptor gene and risk of primary biliary cirrhosis: a meta-analysis. J. Gastroenterol. Hepatol. 29:4 (2014), 706–715.
98. [98] Perna, L., Butterbach, K., Haug, U., Schottker, B., Muller, H., Arndt, V., et al. Vitamin D receptor genotype rs731236 (Taq1) and breast cancer prognosis. Cancer Epidemiol. Biomarkers Prev. 22:3 (2013), 437–442.
99. [99] Vasilopoulos, Y., Sarafidou, T., Kotsa, K., Papadimitriou, M., Goutzelas, Y., Stamatis, C., et al. VDR TaqI is associated with obesity in the Greek population. Gene 512:2 (2013), 237–239.
100. [100] Tanaka, K., Miyake, Y., Hanioka, T., Arakawa, M., VDR gene polymorphisms, interaction with smoking and risk of periodontal disease in Japanese women: the Kyushu Okinawa maternal and child health study. Scand. J. Immunol. 78:4 (2013), 371–377.
101. [101] Agliardi, C., Guerini, F.R., Saresella, M., Caputo, D., Leone, M.A., Zanzottera, M., et al. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1*15-positive individuals. Brain Behav. Immun. 25:7 (2011), 1460–1467.
102. [102] Ovsyannikova, I.G., Dhiman, N., Haralambieva, I.H., Vierkant, R.A., O'Byrne, M.M., Jacobson, R.M., et al. Rubella vaccine-induced cellular immunity: evidence of associations with polymorphisms in the Toll-like, vitamin A and D receptors, and innate immune response genes. Hum. Genet. 127:2 (2010), 207–221.
103. [103] Wang, L., Hara, K., Van Baaren, J.M., Price, J.C., Beecham, G.W., Gallins, P.J., et al. Vitamin D receptor and Alzheimer's disease: a genetic and functional study. Neurobiol. Aging 8 (1844), e1–e9.
104. [104] Dickinson, J.L., Perera, D.I., van der Mei, A.F., Ponsonby, A.L., Polanowski, A.M., Thomson, R.J., et al. Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult. Scler. 15:5 (2009), 563–570.
105. [105] de la Torre, M.S., Torres, C., Nieto, G., Vergara, S., Carrero, A.J., Macias, J., et al. Vitamin D receptor gene haplotypes and susceptibility to HIV-1 infection in injection drug users. J. Infect. Dis. 197:3 (2008), 405–410.
106. [106] Kelly, J.L., Drake, M.T., Fredericksen, Z.S., Asmann, Y.W., Liebow, M., Shanafelt, T.D., et al. Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma. Cancer Causes Control 23:7 (2012), 1017–1029.
107. [107] Kosiniak-Kamysz, A., Marczakiewicz-Lustig, A., Marcinska, M., Skowron, M., Wojas-Pelc, A., Pospiech, E., et al. Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects. Melanoma Res. 24:4 (2014), 388–396.
108. [108] Mutti, D.O., Cooper, M.E., Dragan, E., Jones-Jordan, L.A., Bailey, M.D., Marazita, M.L., et al. Vitamin D receptor (VDR) and group-specific component (GC, vitamin D-binding protein) polymorphisms in myopia. Invest. Ophthalmol. Visual Sci. 52:6 (2011), 3818–3824.
109. [109] Butler, M.W., Burt, A., Edwards, T.L., Zuchner, S., Scott, W.K., Martin, E.R., et al. Vitamin D receptor gene as a candidate gene for Parkinson disease. Ann. Hum. Genet. 75:2 (2011), 201–210.
110. [110] Jacobs, E.T., Martinez, M.E., Campbell, P.T., Conti, D.V., Duggan, D., Figueiredo, J.C., et al. Genetic variation in the retinoid X receptor and calcium-sensing receptor and risk of colorectal cancer in the colon cancer family registry. Carcinogenesis 31:8 (2010), 1412–1416.
111. [111] Anderson, L.N., Cotterchio, M., Cole, D.E., Knight, J.A., Vitamin D-related genetic variants, interactions with vitamin D exposure, and breast cancer risk among caucasian women in Ontario. Cancer Epidemiol. Biomarkers Prev. 20:8 (2011), 1708–1717.
112. [112] Jorde, R., Schirmer, H., Wilsgaard, T., Bogeberg Mathiesen, E., Njolstad, I., Lochen, M.L., et al. The DBP phenotype Gc-1f/Gc-1f Is associated with reduced risk of cancer. The tromso study. PLoS One, 10(5), 2015, e0126359.
113. [113] Janssens, W., Bouillon, R., Claes, B., Carremans, C., Lehouck, A., Buysschaert, I., et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 65:3 (2010), 215–220.
114. [114] Peng, Q., Yang, S., Lao, X., Li, R., Chen, Z., Wang, J., et al. Association of single nucleotide polymorphisms in VDR and DBP genes with HBV-related hepatocellular carcinoma risk in a Chinese population. PLoS One, 9(12), 2014, e116026.
115. [115] Kong, J., Xu, F., Qu, J., Wang, Y., Gao, M., Yu, H., et al. Genetic polymorphisms in the vitamin D pathway in relation to lung cancer risk and survival. Oncotarget 6:4 (2015), 2573–2582.
116. [116] Martineau, A.R., Leandro, A.C.C.S., Anderson, S.T., Newton, S.M., Wilkinson, K.A., Nicol, M.P., et al. Association between Gc genotype and susceptibility to TB is dependent on vitamin D status. Eur. Respir. J. 35:5 (2010), 1106–1112.
117. [117] Bakke, P.S., Zhu, G., Gulsvik, A., Kong, X., Agusti, A.G., Calverley, P.M., et al. Candidate genes for COPD in two large data sets. Eur. Res. J. 37:2 (2011), 255–263.
118. [118] Tayeb, M.T., Clark, C., Haites, N.E., Sharp, L., Murray, G.I., McLeod, H.L., CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia. Br. J. Cancer 88:6 (2003), 928–932.
119. [119] Fernandez, P., Zeigler-Johnson, C.M., Spangler, E., van der Merwe, A., Jalloh, M., Gueye, S.M., et al. Androgen metabolism gene polymorphisms, associations with prostate cancer risk and pathological characteristics: a comparative analysis between South African and Senegalese men. Prostate Cancer, 2012, 2012, 798634.
120. [120] Leung, T.F., Wang, S.S., Tang, M.F., Kong, A.P., Sy, H.Y., Hon, K.L., et al. Childhood asthma and spirometric indices are associated with polymorphic markers of two vitamin D 25-hydroxylase genes. Pediatr. Allergy Immunol. 26:4 (2015), 375–382.
121. [121] Morrison, M.A., Silveira, A.C., Huynh, N., Jun, G., Smith, S.E., Zacharaki, F., et al. Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degeneration. Hum. Genomics 5:6 (2011), 538–568.
122. [122] Fuhrman, B.J., Freedman, D.M., Bhatti, P., Doody, M.M., Fu, Y.-P., Chang, S.-C., et al. Sunlight, polymorphisms of vitamin D-related genes and risk of breast cancer. Anticancer Res. 33:2 (2013), 543–551.
123. [123] Shen, H., Bielak, L.F., Ferguson, J.F., Streeten, E.A., Yerges-Armstrong, L.M., Liu, J., et al. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler. Thromb Vasc. Biol. 30:12 (2010), 2648–2654.
124. [124] Fichna, M., Zurawek, M., Januszkiewicz-Lewandowska, D., Gryczynska, M., Fichna, P., Sowinski, J., et al. Association of the CYP27B1C(-1260)A polymorphism with autoimmune Addison's disease. Exp. Clin. Endocrinol. Diabetes 118:8 (2010), 544–549.
125. [125] Bailey, R., Cooper, J.D., Zeitels, L., Smyth, D.J., Yang, J.H.M., Walker, N.M., et al. Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56:10 (2007), 2616–2621.
126. [126] Wilke, R.A., Simpson, R.U., Mukesh, B.N., Bhupathi, S.V., Dart, R.A., Ghebranious, N.R., et al. Genetic variation in CYP27B1 is associated with congestive heart failure in patients with hypertension. Pharmacogenomics 10:11 (2009), 1789–1797.
127. [127] Alloza, I., Otaegui, D., de Lapuente, A.L., Antiguedad, A., Varade, J., Nunez, C., et al. ANKRD55 and DHCR7 are novel multiple sclerosis risk loci. Genes Immun. 13:3 (2012), 253–257.
128. [128] Wang, L.L., Pan, X.L., Wang, Y., Tang, H.D., Deng, Y.L., Ren, R.J., et al. A single nucleotide polymorphism in LRP2 is associated with susceptibility to Alzheimer's disease in the Chinese population. Clin. Chim. Acta 412:3–4 (2011), 268–270.
129. [129] Vargas, T., Bullido, M.J., Martinez-Garcia, A., Antequera, D., Clarimon, J., Rosich-Estrago, M., et al. A megalin polymorphism associated with promoter activity and Alzheimer's disease risk. Am. J. Med. Genet. B Neuropsychiatr. Genet. 153B:4 (2010), 895–902.
130. 3 plasma levels in type 1 diabetes patients. J. Steroid Biochem. Mol. Biol. 121:1–2 (2010), 442–444.